Publications by authors named "David Richman"

Claim this Profile
N
Neuromuscular complications associated with cancer immunotherapy.
Ge Xiong, Catherine Lomen-Herth, David Richman, Tianhong Li

J Natl Cancer Cent· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges to Applied Behavior Analysis: Introduction to the Special Issue.
Timothy D Hackenberg, David M Richman

Perspect Behav Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.
Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel, David P Richman

Nat Biotechnol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells.
Sangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, Jinmin Lee, Darshil Patel, David P Richman

Nat Biotechnol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review.
Ge Xiong, Richard Benjamin Young, Helen Chow, Emanual Maverakis, Ricardo A Maselli, David Paul Richman

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of employment for adults with intellectual and developmental disabilities participating in a postsecondary transition program in the United States.
Lucy Barnard-Brak, David M Richman, Kagendo Mutua, Amy Williamson

J Appl Res Intellect Disabil· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
Dana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, Erik H Niks, Martijn R Tannemaat, David P Richman

J Neuroimmunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to the Special Section: Translating Advanced Quantitative Techniques for Single-Case Experimental Design Data.
Lucy Barnard-Brak, David M Richman, Laci Watkins

Perspect Behav Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, Mazen M Dimachkie, Michael Benatar, David P Richman

Neurology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal number of baseline sessions before changing phases within single-case experimental designs.
Lucy Barnard-Brak, Laci Watkins, David Richman

Behav Processes· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the Relation between Self-reported ASD Symptoms and Sensory Sensitivities from a Community-based Sample of Adults.
Lucy Barnard-Brak, Laci Watkins, David M Richman

Dev Neurorehabil· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the correlation between symptoms of obsessive compulsive disorder and autism spectrum disorder in a community-based sample of adults.
Lucy Barnard-Brak, Laci Watkins, David M Richman

Psychiatry Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle-Specific Kinase Myasthenia Gravis.
Lucia S Borges, David P Richman

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.
Pushpa Narayanaswami, Donald B Sanders, Gil Wolfe, Michael Benatar, Gabriel Cea, David Richman

Neurology· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymectomy and myasthenia gravis.
Robert P Lisak, David P Richman

Proc Natl Acad Sci U S A· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.
Joshua D Green, Richard J Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, David P Richman

BMJ Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Burst Data Points and Single Case Design Studies: A Bayesian N-of-1 Analysis for Estimating Treatment Effect Size.
Lucy Barnard-Brak, David M Richman, Laci Watkins

Perspect Behav Sci· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renewal of fear and avoidance in humans to escalating threat: Implications for translational research on anxiety disorders.
Michael W Schlund, Madonna Ludlum, Sandy K Magee, Erin B Tone, Adam Brewer, David M Richman

J Exp Anal Behav· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.
Shruti M Raja, Donald B Sanders, Vern C Juel, Yadollah Harati, A Gordon Smith, David P Richman

Muscle Nerve· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma.
Matthew S Lara, Alaa Afify, Michael P Ellis, Chinh T Phan, David P Richman

Clin Lung Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement.
Antonie D Kline, Joanna F Moss, Angelo Selicorni, Anne-Marie Bisgaard, Matthew A Deardorff, David Richman

Nat Rev Genet· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing wandering risk among individuals with Alzheimer's disease and dementia: a pilot study.
Lucy Barnard-Brak, David M Richman, Donna C Owen

Psychogeriatrics· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telehealth and in-person training outcomes for novice discrete trial training therapists.
Layla A Sump, David M Richman, Anna Marie Schaefer, Laura M Grubb, Adam T Brewer

J Appl Behav Anal· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Donald B Sanders, Yadollah Harati, Vern C Juel, Jau-Shin Lou, Tessa Marburger, David P Richman

Muscle Nerve· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
Donald B Sanders, Vern C Juel, Yadollah Harati, A Gordon Smith, Amanda C Peltier, David P Richman

Muscle Nerve· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis